GPT and metabolic dysfunction-associated steatotic liver disease: The alanine transaminase (ALT) level was mildly elevated in MASLD patients (healthy controls vs. MASLD patients: 19.54 ± 7.74 vs. 25.79±20.31 U/L, P=0.04; Table 1), but both were below the clinical cutoff value of 40 U/L.